Literature DB >> 11741568

Time course and frequency of subtherapeutic anticoagulation for newly prescribed warfarin anticoagulation before elective cardioversion of atrial fibrillation or flutter.

M H Kim1, K Krishnan, S Jain, B F Decena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11741568     DOI： 10.1016/s0002-9149(01)02128-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  3 in total

1.  Rapid achievement of therapeutic anticoagulation positively affects outcome in patients undergoing cardioversion for persistent atrial fibrillation.

Authors:  Ray Cutro; Thomas A Burkart; Anne B Curtis
Journal:  Clin Cardiol       Date:  2006-02       Impact factor: 2.882

2.  Optimal Anticoagulation Strategy for Cardioversion in Atrial Fibrillation.

Authors:  Philipp Bushoven; Sven Linzbach; Mate Vamos; Stefan H Hohnloser
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-03-10

3.  Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation.

Authors:  Maartje S Jacobs; Lisa A de Jong; Maarten J Postma; Robert G Tieleman; Marinus van Hulst
Journal:  Eur J Health Econ       Date:  2017-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.